N/A
N=42
Replaceability of Fluoroscopy and Ultrasound in the Evaluation of Hemidiaphragm Excursion
Diaphragm Disease
Bottom Line
View on ClinicalTrials.gov: NCT04098939 ↗Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Diaphragm Function — 4.25 centimeters — p=<0.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Diaphragm evaluation (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Aarhus
- Primary completion
- Jun 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diaphragm Function |
4.25 | <0.05 sig |
Summary
Precise measurement of diaphragm function is difficult. Several methods exist. No are sufficiently validated.
With this study, the investigators wish to investigate the validity of different ultrasound and radiological methods and compare them with inspiratory pressure measurements.
Eligibility Criteria
Inclusion Criteria
- Completed informed consent
- one of the following conditions:
- Healthy participants, control group
- Lung disease group.
- COPD or
- Ideopatic pulmonary fibrosis.
- Heart disease group.
Heart disease that lead to:
- heart transplantat or
- left ventricular assist device.
Exclusion Criteria
- Known diaphragm dysfunction.
- Neuromuscular disease.
- Pleural effusion.
- Pneumothorax.
- In the healthy group: Significant comorbidity that affect heart og lung function (arterial hypertention, mild valve disease and COPD without symptoms are accepted).
- In the healthy group and in the lung disease group: Previous thorax surgery.
Data sourced from ClinicalTrials.gov (NCT04098939). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.